China Feihe Limited CHFLF

Company Overview

China Feihe Limited is a Chinese dairy and infant nutrition company primarily engaged in the production and sale of infant milk formula products, along with complementary nutritional products for children and adults. The company operates within the broader dairy, consumer staples, and nutritional health industries, with its core business centered on premium infant formula marketed under the Feihe brand portfolio. Revenue is driven largely by high-end and super-premium infant formula products sold in China through offline retail channels, maternal and infant specialty stores, e-commerce platforms, and direct distribution networks.

Founded in 1962 in Heilongjiang Province, the company evolved from a regional dairy manufacturer into one of China’s largest domestic infant formula producers. China Feihe has emphasized vertically integrated dairy operations, controlling parts of the supply chain from dairy farming and raw milk sourcing to manufacturing and distribution. Its strategic positioning has focused on domestically produced premium formula tailored to Chinese consumers, particularly following heightened consumer sensitivity around food safety and imported dairy products in China. The company is publicly traded on the Hong Kong Stock Exchange and is commonly associated with the “Feihe” infant nutrition brand family.

Business Operations

China Feihe conducts its operations primarily through its infant nutrition and dairy businesses, with infant milk formula representing the dominant contributor to revenue. Its principal business units include Infant Milk Formula Products, Adult Milk Powder Products, and nutritional supplement offerings. The company markets products across multiple pricing tiers, though premium infant formula remains its central growth engine. Its operational model includes dairy farming, raw milk procurement, research and development, manufacturing, marketing, and nationwide distribution.

The company’s operations are concentrated in mainland China, though it maintains certain international production and sourcing relationships. China Feihe controls manufacturing facilities and dairy farms mainly located in Heilongjiang Province and other regions of China. The company has also invested in overseas supply chain assets, including operations connected to Canada through Canada Royal Milk ULC, which has been associated with milk processing and infant formula production capabilities. China Feihe has emphasized proprietary formulation research, nutrition science capabilities, and integrated supply chain management as important operational assets supporting product quality control and brand positioning.

Strategic Position & Investments

China Feihe’s strategic direction has focused on strengthening its premium infant formula leadership in China, expanding research and development capabilities, and increasing penetration in lower-tier cities and emerging consumer segments. The company has invested heavily in branding, maternal and infant retail relationships, and product innovation targeting early childhood nutrition. It has also pursued initiatives tied to pediatric nutrition, functional dairy products, and broader family-oriented nutritional offerings amid demographic and consumption shifts in China.

The company has made notable investments in upstream dairy infrastructure, production automation, and nutrition research facilities. China Feihe has highlighted partnerships with academic and medical institutions to support infant nutrition research and product development. Investments associated with Canada Royal Milk ULC represented part of the company’s international supply chain and production strategy. The company has also increased emphasis on scientific branding and domestically sourced fresh milk supply chains as differentiators within China’s competitive infant formula market.

Geographic Footprint

China Feihe is headquartered in Beijing, China, with major production and agricultural operations concentrated in Heilongjiang Province and other parts of mainland China. Its primary commercial market is China, where it distributes products nationwide through extensive retail and e-commerce channels. The company has established a strong presence in both higher-income urban centers and lower-tier regional markets.

Internationally, China Feihe maintains limited but strategically relevant operational exposure through investments and supply chain activities in Canada and relationships connected to overseas dairy sourcing and production. While the company’s revenue base remains overwhelmingly tied to mainland China, its international investments support manufacturing diversification, quality assurance initiatives, and access to global dairy resources. Its market influence is therefore strongest in Asia, particularly within the Chinese infant nutrition sector.

Leadership & Governance

China Feihe was founded by predecessors linked to the original Heilongjiang dairy enterprise, while modern corporate leadership has been strongly associated with entrepreneur Leng Youbin, who played a central role in transforming the company into a leading domestic infant formula producer. The company’s leadership philosophy has emphasized product safety, vertically integrated supply chains, scientific research, and long-term brand trust within China’s maternal and infant nutrition market.

Key executives and directors associated with China Feihe include:

• Leng Youbin – Chairman of the Board and Chief Executive Officer
• Liu Hua – Executive Director
• Lu Guang – Executive Director
• Jiang Xiu Yun – Executive Director
• Cai Fangliang – Independent Non-Executive Director
• Victor Yip – Independent Non-Executive Director

Public disclosures, including Hong Kong Stock Exchange filings, annual reports, and company investor materials, consistently identify management’s strategic priorities as premiumization, research-driven product development, supply chain integration, and expansion of consumer trust in domestically produced infant nutrition products.